Weiji Lin
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 6
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies 10
-
- Traditional Chinese Medicine Analysis 2
-
- Autoimmune and Inflammatory Disorders Research 4
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
-
- Cytokine Signaling Pathways and Interactions 3
-
- Ginseng Biological Effects and Applications 2
-
- COVID-19 Clinical Research Studies 2
Weiji Lin
29 papers receiving 729 citations
Peers
Comparison fields: 5 of 107
- Pharmacology 103
- Rheumatology 159
- Complementary and alternative medicine 74
- Immunology 149
- Molecular Medicine 20
Countries citing papers authored by Weiji Lin
This map shows the geographic impact of Weiji Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiji Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiji Lin more than expected).
Fields of papers citing papers by Weiji Lin
This network shows the impact of papers produced by Weiji Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiji Lin. The network helps show where Weiji Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiji Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 11 | |
| 3 | 2023 | 15 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 18 | |
| 7 | 2023 | 36 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 28 | |
| 10 | 2022 | 37 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 65 | |
| 14 | 2020 | 6 | |
| 15 | 2020 | 24 | |
| 16 | 2020 | 21 | |
| 17 | 2020 | 8 | |
| 18 | 2019 | 15 | |
| 19 | 2019 | 40 | |
| 20 | 2000 | 5 |
About Weiji Lin
Weiji Lin is a scholar working on Pharmacology, Rheumatology, Complementary and alternative medicine, Immunology and Hematology, having authored 29 papers that have together received 744 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (10 papers), Pharmacological Effects of Natural Compounds (6 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Ginseng Biological Effects and Applications (2 papers), COVID-19 Clinical Research Studies (2 papers) and Traditional Chinese Medicine Analysis (2 papers). The work is most often cited by research in Pharmacology (103 citations), Rheumatology (159 citations), Complementary and alternative medicine (74 citations), Immunology (149 citations) and Molecular Medicine (20 citations). Weiji Lin has collaborated with scholars based in China and Taiwan. Frequent co-authors include Shenghao Tu, Ying Huang, Pan Shen, Xin Ba, Kai Qin, Zhe Chen, Yao Huang, Liang Han, Xuan Deng and Yu Wang. Their work appears in journals such as Frontiers in Immunology, Journal of Ethnopharmacology, Evidence-based Complementary and Alternative Medicine, Drug Design Development and Therapy and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.